Carmignac Gestion boosted its position in shares of Equifax, Inc. (NYSE:EFX – Free Report) by 94.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 710,685 shares of the credit services provider’s stock after buying an additional 346,080 shares during the period. […]

Carmignac Gestion cut its stake in ServiceNow, Inc. (NYSE:NOW – Free Report) by 75.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 371,803 shares of the information technology services provider’s stock after selling 1,142,046 shares during the quarter. Carmignac […]

Carmignac Gestion cut its holdings in shares of Block, Inc. (NYSE:XYZ – Free Report) by 60.2% during the second quarter, Holdings Channel reports. The fund owned 1,287,026 shares of the technology company’s stock after selling 1,946,800 shares during the period. Block makes up about 1.3% of Carmignac Gestion’s portfolio, making the stock its 23rd biggest […]

Maven Securities LTD grew its holdings in shares of News Corporation (NASDAQ:NWSA – Free Report) by 21.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 271,079 shares of the company’s stock after purchasing an additional 48,622 shares during the period. Maven Securities LTD owned approximately 0.05% of […]

Carmignac Gestion raised its stake in McKesson Corporation (NYSE:MCK – Free Report) by 97.3% during the second quarter, HoldingsChannel.com reports. The fund owned 626,904 shares of the company’s stock after purchasing an additional 309,183 shares during the quarter. McKesson comprises approximately 6.1% of Carmignac Gestion’s holdings, making the stock its 4th biggest position. Carmignac Gestion’s […]

Carmignac Gestion purchased a new stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 44,475 shares of the company’s stock, valued at approximately $5,903,000. Other hedge funds and other institutional investors also recently modified […]

Keenan Capital LLC bought a new stake in Toast, Inc. (NYSE:TOST – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,115,979 shares of the company’s stock, valued at approximately $31,047,000. Toast comprises 6.1% of Keenan Capital LLC’s investment portfolio, making the stock […]

Maven Securities LTD acquired a new stake in shares of Brighthouse Financial, Inc. (NASDAQ:BHF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,235 shares of the company’s stock, valued at approximately $1,914,000. Maven Securities LTD owned about 0.05% of Brighthouse […]

Maven Securities LTD purchased a new position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 40,000 shares of the company’s stock, valued at approximately $3,551,000. A number of other hedge funds and other institutional investors […]

Allworth Financial LP cut its stake in Prologis, Inc. (NYSE:PLD – Free Report) by 2.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned 230,599 shares of the real estate investment trust’s stock after selling 4,806 shares during the period. Allworth Financial LP’s holdings in Prologis were worth $31,239,000 as of its most recent […]

Maven Securities LTD acquired a new position in shares of Huntington Ingalls Industries, Inc. (NYSE:HII – Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 26,482 shares of the aerospace company’s stock, valued at approximately $7,412,000. Maven Securities LTD owned about 0.07% of Huntington […]

Maven Securities LTD bought a new position in shares of Organon & Co. (NYSE:OGN – Free Report) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 434,200 shares of the company’s stock, valued at approximately $5,879,000. Other hedge funds have also recently bought and sold shares of the company. Royal Bank of Canada increased […]